Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Express Scripts
Dow
Boehringer Ingelheim
Harvard Business School

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pipamperone

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Pipamperone: Patents, clinical trial progress, indications

Pipamperone is an investigational drug.

There have been 4 clinical trials for Pipamperone. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2011.

The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Schizophrenia. The leading clinical trial sponsors are PharmaNeuroBoost N.V., Hannover Medical School, and [disabled in preview].

There is one US patent protecting this investigational drug and fifteen international patents.

Recent Clinical Trials for Pipamperone
TitleSponsorPhase
Pharmacovigilance in Gerontopsychiatric PatientsHannover Medical SchoolPhase 3
POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic SchizophreniaPharmaNeuroBoost N.V.Phase 2
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)PharmaNeuroBoost N.V.Phase 3

See all Pipamperone clinical trials

Clinical Trial Summary for Pipamperone

Top disease conditions for Pipamperone
Top clinical trial sponsors for Pipamperone

See all Pipamperone clinical trials

US Patents for Pipamperone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pipamperone   See Pricing Quinolone-based compounds, formulations, and uses thereof University of South Florida (Tampa, FL) Northeastern University (Boston, MA)   See Pricing
Pipamperone   See Pricing Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors Bristol-Myers Squibb Company (Princeton, NJ)   See Pricing
Pipamperone   See Pricing Compositions and methods for treating Dengue virus infection The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA)   See Pricing
Pipamperone   See Pricing Compounds useful for the treatment of metabolic disorders and synthesis of the same North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC)   See Pricing
Pipamperone   See Pricing Multivalent ligands targeting VEGFR The Methodist Hospital System (Houston, TX)   See Pricing
Pipamperone   See Pricing 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists Bristol-Myers Squibb Company (Princeton, NJ)   See Pricing
Pipamperone   See Pricing Method for metabolomic sample preparation based on ionic liquid dispersive liquid-liquid microextraction Agilent Technologies, Inc. (Santa Clara, CA)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pipamperone

Drugname Country Document Number Estimated Expiration Related US Patent
Pipamperone China 103987697 2031-10-14   See Pricing
Pipamperone European Patent Office 2766345 2031-10-14   See Pricing
Pipamperone European Patent Office 2899183 2031-10-14   See Pricing
Pipamperone Spain 2572908 2031-10-14   See Pricing
Pipamperone Spain 2699226 2031-10-14   See Pricing
Pipamperone India 2806CHN2014 2031-10-14   See Pricing
Pipamperone Japan 2014528479 2031-10-14   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Baxter
Colorcon
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.